Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Addressing Cancer Immunotherapy Research in Iran: Adoptive Cell Therapy on the Horizon Publisher Pubmed



Khatami F1 ; Torabirahvar M1 ; Kiani J2 ; Naderi M3 ; Ahmadbeigi N3
Authors

Source: Cytotherapy Published:2018


Abstract

Recent advances in immunotherapeutic modalities have profoundly changed the prospect of cancer treatment. These modalities mainly focus on modulating the immune response toward tumor cells by using monoclonal antibodies, cancer vaccines, adoptive cell transfer or combination of these methods. In the last few years, Iranian scientists have conducted several projects in these arenas. Here, we provide an overview of these studies and analyze the quality and trend of publications in each sub-specialty of the field. In addition, the contribution of different universities and scientific institutes is assessed. This study may benefit scientific community and policymakers to plan future cancer immunotherapies in Iran and other countries. © 2018 International Society for Cellular Therapy
Related Docs
View other Related Docs
1. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
2. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
3. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (14)
Mohammad Hossein Modarressi (1)
Other Related Docs
4. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
5. Cell Transfer-Based Immunotherapies in Cancer: A Review, IUBMB Life (2020)
6. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)
7. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
8. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
9. Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor, Iranian Biomedical Journal (2020)
10. T Cell Engineered With a Novel Nanobody-Based Chimeric Antigen Receptor Against Vegfr2 As a Candidate for Tumor Immunotherapy, IUBMB Life (2019)
11. Introduction on Cancer Immunology and Immunotherapy, Cancer Immunology: A Translational Medicine Context# Second Edition (2020)
12. Monoclonal Antibodies for Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
13. Introduction on Cancer Immunology and Immunotherapy, Cancer Immunology: A Translational Medicine Context (2015)
14. A Vhh-Based Anti-Muc1 Chimeric Antigen Receptor for Specific Retargeting of Human Primary T Cells to Muc1-Positive Cancer Cells, Cell Journal (2021)
15. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers (2015)
16. Combination Therapy, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
17. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
18. Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, Second Edition, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
19. Cancer Immunotherapy Confers a Global Benefit, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
20. Cancer Immunology: A Translational Medicine Context, Cancer Immunology: A Translational Medicine Context (2015)